The stock has demonstrated strong overall performance, gaining 95.2% over the past year and significantly outperforming the broader market. The price has risen from $228.02 on December 31, 2025, to $265.63 on March 31, 2026, representing a 16.5% gain over the last three months and a 24.2% increase over the past month. The current price of $265.63 is near the top of its 52-week range of $108.66 to $283.76, trading at approximately 93.6% of its 52-week high, indicating a strong bullish trend. The stock's relative strength metrics are positive, showing significant outperformance against the S&P 500 over the 1-month, 3-month, and 1-year periods.

Revenue for the latest quarter (Q2 2026) was $8.28 billion, showing a 23.1% year-over-year growth from the same quarter last year. Profitability has improved, with net income reaching $223 million in Q2 2026, up from $117 million in Q2 2025, and the net margin expanding to 2.69% from 1.74%. The company's financial health is characterized by a high debt-to-equity ratio of 2.22, indicating significant leverage, but it maintains a current ratio of approximately 1.0 and generates substantial free cash flow, with TTM free cash flow reported at $1.47 billion. Operational efficiency is strong, as evidenced by a high return on equity (ROE) of 43.4% and a return on assets (ROA) of 5.35%, suggesting effective use of shareholder capital and assets.